Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.

Gerald ChiC Michael GibsonArzu KalayciAlexander T CohenAdrian F HernandezRussell D HullFarima KaheMehrian JafarizadeSadaf SharfaeiYuyin LiuRobert A HarringtonSamuel Z Goldhaber

Published in: Intensive care medicine (2019)

http://www.clinicaltrials.gov . Unique identifier: NCT01583218.

Keyphrases

venous thromboembolism
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
clinical trial
direct oral anticoagulants
peritoneal dialysis
study protocol
phase iii
patient reported outcomes
phase ii